The University of Minnesota Medical School received funding from the Parsemus Foundation to start a study focusing on the widely-used diabetes medication known as metformin. The key question: can this economical and available drug be used to help fight COVID-19? A randomized, controlled study planned will help two co-principal investigators pursue what could be a materially breakthrough in the search for treatments targeting COVID-19. Although the recent grant support from the Parsemus Foundation is a healthy start, the University of Minnesota investigators need additional capital to complete the entire clinical trial.
An Important Goal: A Generic Low Cost Approach Targeting COVID-19
The CDC forecasts predict 1,300 to 5,500 new COVID-19 hospitalizations per day by Oct. 12 in the U.S. alone. This means that a treatment that reduces hospitalization by about 50-60%, as evidenced by observational data, could potentially prevent thousands of hospitalizations each day in the U.S.. With generics available for less than $4 per month from manufacturers around the globe, metformin also has the advantage that it can be used immediately and inexpensively worldwide. Metformin is al...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).